Author/Authors :
Ahmady ، Hosyin Neuroscience Research Center - Baqiyatallah University of Medical Sciences , Afrand ، Mahsa Roya Physiotherapy Clinic , Motaqi ، Monireh Physiotherapy Research Center, School of Rehabilitation - Shahid Beheshti University of Medical Sciences , Meftahi ، Gholam Hossein Neuroscience Research Center - Baqiyatallah University of Medical Sciences
Abstract :
Neurodegenerative diseases (NDs), such as Alzheimer s disease (AD), Parkinson s disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington s disease (HD), are defined by aberrant protein accumulation, brain atrophy, and gradual decline of neuronal function. Despite the considerable endeavors devoted to discovering treatments for NDs in recent decades, the demand for efficient therapeutic agents persists. Sertoli cells (SCs) play a crucial role in providing a supportive structure and environment for the development of germ cells. SCs, whether transplanted as xenogeneic or allogeneic cells, present a viable choice for enhancing graft persistence via the release of immunomodulatory and trophic factors, including neurturin (NTN), platelet-derived growth factor, Fas (CD95) ligand (FasL), glial-derived neurotrophic factor, interleukin 1 (IL1), brain-derived neurotrophic factor, interleukin 6 (IL6), transforming growth factors, and vascular growth factor, that protect replaced cells and tissues from the immune system. However, there is currently no cohesive evidence regarding the neuroprotective influence of the transplantation of SCs on NDs. Therefore, this review focuses on assessing stem cells neuroprotective impact on neurodegenerative diseases in pre-clinical settings and presenting cohesive information. A comprehensive search was conducted between 2000 and 2022. In the identification stage, after a comprehensive search across databases, including Web of Science, Scopus, and PubMed/Medline, 103 papers were obtained. The search conducted in the present study yielded a total of nine relevant papers on the therapeutic effect of the transplantation of SCs on NDs. It was found that the transplantation of SCs exhibits a promising impact on enhancing the symptoms of neurological diseases in rats. The findings highlight the need for multiple standardized pre-clinical trials to find reliable information to confirm the utilization of the transplantation of SCs and the reduction of the symptoms of neurodegenerative diseases.
Keywords :
Neurodegenerative diseases , Huntington s disease , Parkinson s disease , Cerebellar Ataxia , Sertoli cells (SCs)
